Study on co-amorphous emerging solubilization behavior after gelation during dissolution: The importance of complexation and anti-crystallization

Int J Pharm. 2024 Oct 25:664:124592. doi: 10.1016/j.ijpharm.2024.124592. Epub 2024 Aug 17.

Abstract

Co-amorphous (CM) is a promising technology for enhancing the aqueous solubility of insoluble drugs, but the gelation phenomenon has often occurred during the dissolution process and seriously threatened their solubility/dissolution performance. Therefore, it's quite important to design favorable CM systems to alleviate or even avoid the adverse effects of gelation phenomenon. In this study, CM systems of taxifolin (TAX) and oxymatrine (OMT) (TAX-OMT CMs) were constructed to improve the solubility and dissolution properties of TAX. Interestingly, TAX-OMT CMs gradually aggregated and obviously gelled during dissolution, but the solubility and dissolution of TAX in TAX-OMT CMs were significantly enhanced compared to crystalline TAX. Consequently, the underlying solubilization mechanisms of TAX-OMT CMs after gelation were systematically explored. For one thing, the complexation between the two components in TAX-OMT CMs was verified by phase solubility, fluorescence spectroscopy and isothermal titration calorimetry. For another, the residual solids of TAX-OMT CMs after dissolution evaluation were thoroughly characterized by means of powder X-ray diffraction, fourier transform infrared spectroscopy, scanning electron microscopy, which showed the anti-crystallization property of TAX-OMT CMs. Furthermore, molecular simulation demonstrated the intermolecular interactions of TAX-OMT CMs alone and TAX-OMT complexes in aqueous solution. Finally, pharmacokinetics study in rats suggested that the bioavailability of TAX in TAX-OMT CM (1:2) was approximately 5.5-fold higher than that of crystalline TAX after oral administration. Collectively, this study reveals the importance of complexation and anti-crystallization effects of CM systems on maintaining solubilization behavior after gelation, providing an effective strategy to improve the absorption performance of pharmaceutical CM systems.

Keywords: Anti-crystallization; Co-amorphous; Complexation; Gelation; Solubilization; Taxifolin.

MeSH terms

  • Animals
  • Biological Availability
  • Crystallization*
  • Drug Liberation
  • Gels*
  • Male
  • Matrines
  • Quercetin / administration & dosage
  • Quercetin / chemistry
  • Quinolizines* / administration & dosage
  • Quinolizines* / chemistry
  • Quinolizines* / pharmacokinetics
  • Rats
  • Rats, Sprague-Dawley
  • Solubility*
  • Spectroscopy, Fourier Transform Infrared / methods
  • X-Ray Diffraction

Substances

  • Gels
  • oxymatrine
  • Quinolizines
  • Quercetin
  • Matrines